Supriya Lifescience
Supriya Lifescience Share Price

Supriya Lifescience Share Price

NSE: SUPRIYA

|

BSE: 543434

|

Pharmaceuticals

100% Buy

₹711.30

-₹9.00 (-1.25%) Last updated on 18 Jul, 2025 | 15:55 IST

Supriya Lifescience Overview

Market cap
Market Cap Switch₹5,725 Crs
Open
₹720.30
Prev. Close
₹720.30
Circuit range
₹853.55 - ₹569.05
Day range
₹710.00 - ₹725.00
Year range
₹368.00 - ₹842.00
Volume
99,144
Avg. traded
₹716.82
Revenue (12m)
₹696 Crs

About Supriya Lifescience

Supriya Lifescience Limited is an Indian pharmaceutical company. It was established in 1987 and is headquartered in Mumbai. It is a prominent global producer of active pharmaceutical ingredients (APIs).

In API manufacturing, the company specialises in products across diverse therapeutic segments such as anti-histamines, anti-allergics, vitamins, anaesthetics and anti-asthmatics.

The company has a worldwide presence, reaching 86 countries. It’s domestic operations are spread across 12 states in India. Its product portfolio of active pharmaceutical ingredients includes more than 38 products.

The market capitalisation of Supriya Lifescience Limited stood at over ₹2,400 crore as of January 19, 2024. Supriya Lifescience share price has gained 42% in the last three years.

Supriya Lifescience Limited business operations

Supriya Lifescience Limited is a major supplier of active pharmaceutical ingredients (APIs) globally. It ensures efficient procurement from both Indian and global sources including China, South Korea and Belgium.

The company serves many well-known global pharmaceutical firms. A few of them are Syntec Do Brasil LTDA, American International Chemical Inc, AT Planejamento E Desenvolvimento De Negocios Ltd, Suan Farma Inc, Acme Generics LLP, Akum Drugs Ltd and Mankind Pharma Ltd, among others. Approximately 45% of the company's revenue comes from its top 10 customers.

In FY23, the company generated 20% of its revenues domestically and 80% from exports. Asia and Europe contributed the most to the company's revenue, followed by Latin America and North America.

The company operates a backwards-integrated production facility located in Lote, Parshuram in Maharashtra. It spans 23,806 square meters and is divided into four blocks based on therapy. The facility includes a reactor with a capacity of 547 KL. It has approvals from various regulatory bodies including USFDA, EDQM and EUGMP. The company has also received marketing auithorisations from AIFA in Italy, TGA in Australia, BfArM in Germany, KFDA in Korea, PMDA in Japan, SFDA in China and COFEPRIS in Mexico.

The facility features designated sections for warehouse, production, finished products and dedicated blocks for different therapeutic segments. As part of the company's capacity expansion plan, the facility is projected to reach approximately 1000+ KL by 2024. The facility in Lote also houses a DSIR-approved R&D facility. The company has plans to expand its product segments within its portfolio and is in the process of establishing two new R&D centres.

In FY23, Supriya Lifescience Limited expanded its manufacturing capabilities by incorporating four new laboratories into its existing facility at Lote. Construction is also underway for a manufacturing facility with a capacity of 330 KL. It is anticipated to become operational by February 2024.

By the end of FY23, the company had submitted 15 active Drug Master Files (DMFs) to the USFDA. It also submitted nine active Certificates of Suitability (CEPs) to the European Directorate for the Quality of Medicines and Healthcare for its API products.

Financial Highlights

The company’s revenue from operations in FY23 stood at ₹460.9 crore, down 13.2% compared to ₹530 crore in FY22. The net profit dropped to ₹89.8 crore in FY23 compared to ₹151.8 crore in FY22. In FY23, the company’s earnings before interest, tax, depreciation and amortization (EBITDA) decreased to ₹129 crore compared to ₹214 crore in FY22. The company's earnings per share (EPS) stood at ₹11.16 in FY23 compared to ₹18.86 in FY22.

  • Chart
  • Fundamentals
  • Financials
  • Shareholdings
  • Events
  • Peers
  • News
  • FAQs

Supriya Lifescience Share Price Chart

Please wait...

Supriya Lifescience Key Indicators

P/E ratio
30.45
P/B ratio
5.6
ROE
15.73%
ROCE
22.31%
Dividend yield
0.14%
Debt/Equity ratio
EPS
14.8

Investment Checklist: (3/6)

passed

Equity returns

not passed

Dividend returns

not passed

Safety factor

passed

Growth factor

passed

Debt vs Equity

NA

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst Ratings:

Buy

Buy

100%

Hold

0%

Sell

0%

This analysis is based on the reviews of 1 experts in the last 7 days

Supriya Lifescience Financial Ratios

  • Profitability

  • Operational

  • Valuation

Operating profit margin

28.85%

Net profit margin

18.41%

ROE

15.73%

ROA

13.66%

ROCE

22.31%

Supriya Lifescience Shareholder returns

1 day
-1.25%
1 week
+3.44%
1 month
+6.03%
3 months
-4.58%
1 year
+77.87%
3 years
+80.83%
5 years
+81.99%

Revenue Statement

All values are in ₹ Crores (Cr)
RevenueNo Sort
Operating ProfitNo Sort
Net ProfitNo Sort
No data found

Cash Flow

All values are in ₹ Crores (Cr)
OperatingNo Sort
InvestingNo Sort
FinancingNo Sort
No data found

Balance Sheet

All values are in ₹ Crores (Cr)
Empty state

No data available at the moment

Supriya Lifescience Share Price History

DayOpenCloseChange %
04-Jul-25
₹722.00
₹735.30
+1.28%
03-Jul-25
₹729.35
₹726.00
+0.04%
02-Jul-25
₹720.00
₹725.70
+0.17%
01-Jul-25
₹711.75
₹724.50
+2.18%
30-Jun-25
₹688.75
₹709.05
+2.94%
27-Jun-25
₹683.20
₹688.80
+1.20%
26-Jun-25
₹673.80
₹680.60
+1.44%
25-Jun-25
₹685.00
₹670.95
-1.63%

Supriya Lifescience Shareholding Pattern

CategoryMar 2025Dec 2024Sep 2024Jun 2024
Promoters
68.30%
68.30%
68.30%
68.30%
Foreign institutions-FII
7.19%
6.52%
6.03%
4.95%
Other domestic institutions
3.60%
4.25%
4.83%
5.35%
Retail and other
20.26%
20.26%
20.23%
21.27%
Mutual Funds
0.66%
0.67%
0.62%
0.13%

Corporate Actions

  • Dividend • ₹0.8/share

    Ex date 20 Sep 2024

    expand tab
  • Dividend • ₹0.6/share

    Ex date 15 Sep 2023

    expand tab

Popular Stocks

PriceNo Sort
Change %No Sort
HDFC Bank₹1,957.40-₹29.50 (-1.48%)
Indian Energy Exchange₹203.14-₹2.61 (-1.27%)
Indian Railway Finance Corp₹133.84-₹1.07 (-0.79%)
Indian Railway Tourism Corp₹765.30-₹9.45 (-1.22%)
ITC₹422.75-₹1.20 (-0.28%)
JIO FIN SERVICES LTD₹316.85-₹1.30 (-0.41%)
Reliance₹1,476.00-₹0.40 (-0.03%)
Tata Motors₹680.25-₹1.45 (-0.21%)
Tata Power₹407.90-₹5.55 (-1.34%)
Wipro₹266.95+₹6.35 (2.44%)

FAQs on Supriya Lifescience

What is the share price of Supriya Lifescience today?

chevron-up
Supriya Lifescience share price is ₹ 711.30 as on 18 Jul, 2025 | 15:55 IST.

What are the high & low stock price of Supriya Lifescience today?

chevron-up
Supriya Lifescience stock price hit a high of ₹ 725.00 and low of ₹ 710.00 as on 18 Jul, 2025 | 15:55 IST.

What is the market cap of Supriya Lifescience?

chevron-up
The market cap of Supriya Lifescience is ₹ 5,724.74 Crores as on 18 Jul, 2025 | 15:55 IST.

What are the the 52-week high and low share prices of Supriya Lifescience stock on the NSE?

chevron-up
52-week high stock Price of Supriya Lifescience is ₹ 842.00 and Low Price is ₹ 368.00 as on 18 Jul, 2025 | 15:55 IST.

What are the stock symbols of Supriya Lifescience?

chevron-up
The stock symbol of Supriya Lifescience is NSE: SUPRIYA on the NSE, BSE: 543434 on the BSE, and the ISIN is INE07RO01027.

Can I buy Supriya Lifescience shares on Holidays?

chevron-up
No, shares of Supriya Lifescience or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Supriya Lifescience shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.

What is the PE and PB ratio of Supriya Lifescience?

chevron-up
The PE and PB ratio of Supriya Lifescience is 30.45 and 5.6 respectively, as on 18 Jul, 2025 | 15:55 IST.

What are the returns on Supriya Lifescience shares?

chevron-up
The historical returns for Supriya Lifescience shares are 77.87 for 1 year, 80.83 for 3 year and 81.99 for 5 year.